Predictors of Optical Coherence Tomography-Defined Calcified Nodules in Patients With Acute Coronary Syndrome - A Substudy From the TACTICS Registry.

Acute coronary syndrome Calcified nodules Coronary artery disease Optical coherence tomography

Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
26 Jun 2024
Historique:
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 26 6 2024
Statut: aheadofprint

Résumé

Recent studies suggest that the presence of calcified nodules (CN) is associated with worse prognosis in patients with acute coronary syndrome (ACS). We investigated clinical predictors of optical coherence tomography (OCT)-defined CN in ACS patients in a prospective multicenter registry.Methods and Results: We investigated 695 patients enrolled in the TACTICS registry who underwent OCT assessment of the culprit lesion during primary percutaneous coronary intervention. OCT-CN was defined as calcific nodules erupting into the lumen with disruption of the fibrous cap and an underlying calcified plate. Compared with patients without OCT-CN, patients with OCT-CN (n=28) were older (mean [±SD] age 75.0±11.3 vs. 65.7±12.7 years; P<0.001), had a higher prevalence of diabetes (50.0% vs. 29.4%; P=0.034), hemodialysis (21.4% vs. 1.6%; P<0.001), and Killip Class III/IV heart failure (21.4% vs. 5.7%; P=0.003), and a higher preprocedural SYNTAX score (median [interquartile range] score 15 [11-25] vs. 11 [7-19]; P=0.003). On multivariable analysis, age (odds ratio [OR] 1.072; P<0.001), hemodialysis (OR 16.571; P<0.001), and Killip Class III/IV (OR 4.466; P=0.004) were significantly associated with the presence of OCT-CN. In non-dialysis patients (n=678), age (OR 1.081; P<0.001), diabetes (OR 3.046; P=0.014), and Killip Class III/IV (OR 4.414; P=0.009) were significantly associated with the presence of OCT-CN. The TACTICS registry shows that OCT-CN is associated with lesion severity and poor clinical background, which may worsen prognosis.

Sections du résumé

BACKGROUND BACKGROUND
Recent studies suggest that the presence of calcified nodules (CN) is associated with worse prognosis in patients with acute coronary syndrome (ACS). We investigated clinical predictors of optical coherence tomography (OCT)-defined CN in ACS patients in a prospective multicenter registry.Methods and Results: We investigated 695 patients enrolled in the TACTICS registry who underwent OCT assessment of the culprit lesion during primary percutaneous coronary intervention. OCT-CN was defined as calcific nodules erupting into the lumen with disruption of the fibrous cap and an underlying calcified plate. Compared with patients without OCT-CN, patients with OCT-CN (n=28) were older (mean [±SD] age 75.0±11.3 vs. 65.7±12.7 years; P<0.001), had a higher prevalence of diabetes (50.0% vs. 29.4%; P=0.034), hemodialysis (21.4% vs. 1.6%; P<0.001), and Killip Class III/IV heart failure (21.4% vs. 5.7%; P=0.003), and a higher preprocedural SYNTAX score (median [interquartile range] score 15 [11-25] vs. 11 [7-19]; P=0.003). On multivariable analysis, age (odds ratio [OR] 1.072; P<0.001), hemodialysis (OR 16.571; P<0.001), and Killip Class III/IV (OR 4.466; P=0.004) were significantly associated with the presence of OCT-CN. In non-dialysis patients (n=678), age (OR 1.081; P<0.001), diabetes (OR 3.046; P=0.014), and Killip Class III/IV (OR 4.414; P=0.009) were significantly associated with the presence of OCT-CN.
CONCLUSIONS CONCLUSIONS
The TACTICS registry shows that OCT-CN is associated with lesion severity and poor clinical background, which may worsen prognosis.

Identifiants

pubmed: 38925928
doi: 10.1253/circj.CJ-24-0111
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tomoyo Sugiyama (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.
Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Masahiro Hada (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Eisuke Usui (E)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Yoshihiro Hanyu (Y)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Tatsuhiro Nagamine (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Kai Nogami (K)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Hiroki Ueno (H)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Kazuki Matsuda (K)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Kodai Sayama (K)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Tatsuya Sakamoto (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital.

Nobuaki Kobayashi (N)

Department of Cardiology, Nippon Medical School Chiba Hokusoh Hospital.

Masamichi Takano (M)

Department of Cardiology, Nippon Medical School Chiba Hokusoh Hospital.

Seita Kondo (S)

Division of Cardiology, Department of Medicine, Showa University School of Medicine.

Kohei Wakabayashi (K)

Division of Cardiology, Cardiovascular Center, Showa University Koto-Toyosu Hospital.

Satoru Suwa (S)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital.

Tomotaka Dohi (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine.

Hiroyoshi Mori (H)

Division of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital.

Shigeki Kimura (S)

Department of Cardiology, Yokohama Minami Kyosai Hospital.

Satoru Mitomo (S)

Department of Cardiovascular Medicine, New Tokyo Hospital.

Sunao Nakamura (S)

Department of Cardiovascular Medicine, New Tokyo Hospital.

Takumi Higuma (T)

Division of Cardiology, Department of Internal Medicine, Kawasaki Municipal Tama Hospital.

Junichi Yamaguchi (J)

Department of Cardiology, Tokyo Women's Medical University.

Makoto Natsumeda (M)

Department of Cardiology, Tokai University School of Medicine.

Yuji Ikari (Y)

Department of Cardiology, Tokai University School of Medicine.

Jun Yamashita (J)

Department of Cardiology, Tokyo Medical University Hospital.

Takehiko Sambe (T)

Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine.

Sakiko Yasuhara (S)

Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine.

Takuya Mizukami (T)

Division of Clinical Pharmacology, Department of Pharmacology, Showa University School of Medicine.
Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University.

Myong Hwa Yamamoto (MH)

Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

Toshiro Shinke (T)

Division of Cardiology, Department of Medicine, Showa University School of Medicine.

Classifications MeSH